PVSS11. Assessing Outcomes to Determine Which “Symptoms” Justify Renal Artery Stenting  by Modrall, J. Gregory et al.
PVSS10.
Clinical Value of CTA in Patients with >50% ICA
Stenosis by Duplex Ultrasound
Mohammad I. ElSorady, Heather Hall, Vector Bernhard,
Hisham Bassiouny. Vascular Surgery and Endovascular
Therapy, University of Chicago Hospitals, Chicago, IL
Objectives: CT angiography (CTA) is frequently em-
ployed in current clinical practice to evaluate the extent of
cerebrovascular disease in patients with DU 50% extra-
cranial ICA stenosis. We studied a) the prevalence of addi-
tional clinically significant intracranial or proximal arch
occlusive disease not detected by DU, and b) whether such
CTA findings predict progression in DU ICA stenosis
category.
Methods: From 2005 to 2010, 111 consecutive pa-
tients were studied retrospectively. 81 were asymptom-
atic and 30 symptomatic (TIA, stroke, AF). Kappa agree-
ment between DU stenosis category and CTA was
determined. Findings on CTA considered significant
were 50% intracranial ICA stenosis, proximal CCA
stenosis, intracranial aneurysm, vertebral stenosis or oc-
clusion,50% subclavian stenosis and diffuse atheroscle-
rosis of the aortic arch. Progression of DU ICA stenosis
from 50-79% to 80-99% was determined in relation to
CTA findings.
Results: Patient demographics were similar between
asymptomatic and symptomatic patients Table 1. DU and
CTA were performed within 6 months in 95% of cases.
Agreement between DU and CTA was 0.9 (Kappa). 19%
(21/111) of patients had CTA findings not detected by
DU, of which 17 (21%) were in asymptomatic and 4 (13%)
in symptomatic patients (p0.60, NS) Table 2. Median
follow up was 3.2 years. Progression from 50-79% to 80-
99% was detected in 4 (19%) and in 13 (14.4%) patients
with and without additional CTA findings respectively
(NS).
Conclusions: For patients harboring  50% carotid
bifurcation ICA stenosis by DU, CTA provides minimal
information of clinical use. Progression of stenosis is
unrelated to the presence of remote atherosclerotic
plaque burden as detected on CTA. These findings sug-
gests that CTA is over utilized in clinical practice and
that DU performed in an ICAVL accredited lab is suffi-
cient for planning carotid intervention if necessary.
Asymptomatic Symptomatic
n (%) n (%)
DM 32 (39.5) 12 (40)
HTN 68 (83.9) 28 (93.3)
CAD 38 (46.9) 14 (46.6)
MI 15 (18.5) 8 (26.6)
Smoking 50 (61.7) 16 (53.3)
CHF 5 (6.1) 5 (16.5)
COPD 19 (23.4) 5 (16.6)
Coagulopathy 1 (1.2) 1. (3.3)
Cancer 21 (25.9) 6 (20)
PAD 42 (51.8) 10 (33.3)
Male 34 (41.9) 16 (53.3)
Mean Age 78 78
Additional CTA
Findings Description
Asymptomatic
(n  81)
Symptomatic
(n  30)
Intracranial ICA Stenosis (50%) 1
Proximal CCA Stenosis (50%) 1
Ant. Communicating
A. Aneurysm (2.1mm) 1
Post. Communicating
A Aneurysm (4mm) 1
Stenosis (50%) 1
Occlusion 1
Vertebral A. Stenosis (50%) 7
Occlusion 2
Subclavian Stenosis (50%)
Arch Diffuse
atherosclerosis
4 2
Total 17 4
% 21 13
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Objectives: Severe, symptomatic hypertension (HTN) is
a classic indication for intervention for renal artery stenosis. It
is not clear, however,which “symptoms”merit treatment. For
instance, is angina in a hypertensive patient an indication for
renal artery stenting (RAS)? The purpose of this study was to
assess the blood pressure (BP) response to RAS to determine
which “symptoms” justify intervention.
Methods: Symptoms examined in this study were HTN
urgencies (n25), HTN emergencies (n13), and angina
(n14). By convention, HTN urgency was defined by a
systolic BP  180 mm Hg or diastolic BP  120 mm Hg,
whileHTN emergency also requiredHTN-related symptoms
with hospitalization. Patient-specific response to RAS was
defined using modified AHA reporting guidelines.
Results: The study cohort of 52 patients had a median
age of 66 years (interquartile range 58-72). The BP response
to RAS varied significantly according to the indication for
RAS. HTN emergency provided the highest BP response rate
(85%), while the response rate was significantly lower for
HTN urgency (52%) and angina (7%; P0.03). Only 1 of 14
patients with angina was a BP responder.Multivariate analysis
showed that HTN urgency or emergency were not indepen-
dent predictors of BP response to RAS. Instead, the only
independent predictor of a favorable BP response was the
number of preoperative antihypertensive medications (Odds
Ratio 7.5; 95% Confidence Interval 2.5-22.9; P0.0004),
which is another indicator of the severity of HTN. Interest-
ingly, angina was an independent predictor of failure to re-
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spond to RAS (Odds Ratio 118.6; 95% Confidence Interval
2.8-999.9; P0.013).
Conclusions: HTN urgency and emergency are man-
ifestations of severe HTN, but the number of preoperative
antihypertensive medications proved to be a better predic-
tor of a favorable BP response to RAS. In contrast, angina
was a predictor of failure to respond to stenting, providing
further evidence against the practice of “drive-by” stenting
during coronary interventions.
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Prior Endovascular Intervention Does Not Negatively
Impact on Lower Extremity Bypass Procedures
Sikandar Z. Khan, Reid Ravin, Benjamin Bradley, In-
Kyong Kim, James F. McKinsey. Columbia University
Medical Center, New York, NY
Objectives:Many centers have adopted an endovascular-
first philosophy for the treatment of patients with Criti-
cal Limb Ischemia (CLI). There is a theoretical concern
that endovascular intervention (EI) may negatively
impact on the outcome if future surgical bypass graft
(BPG) is required. In this study, we will evaluate the
impact of prior endovascular intervention compared to
primary BPG on BPG patency and limb salvage in CLI
patients.
Methods: We retrospectively reviewed patients who
underwent lower extremity BPG with and without prior
EI for CLI between 2003-2009. Patients undergoing
primary EI or BPG at an outside hospital were excluded.
Demographics and follow-up data were collected. Pa-
tients were followed up at 1, 3, 6, 12 months and then
yearly. Patencies and limb-salvage were calculated using
Kaplan-Meier.
Results:A total of 232 BPG procedures (178 Femoral-
distal, 54 Femoral-popliteal) were performed in 211 pa-
tients. There were 140 primary BPG and 92 BPG proce-
dures after prior endovascular intervention. Patient
demographics and co-morbidities were not significantly
different except for a higher incidence of congestive heart
failure in the prior endovascular group(P  .014). Venous
conduit was used in 126 (54.3%) BPG procedures. Mean
follow-up was 13.712.4 months. Primary, primary as-
sisted, secondary patency and limb salvage were not signif-
icantly different between primary BPG and BPG with prior
endovascular for both venous and prosthetic conduits
(Table).
Conclusions: Both primary BPG and BPG after prior
endovascular intervention provided similar results of pa-
tency and limb salvage in similar patients with CLI. An
endovascular first policy for limb salvage is reasonable in
CLI patients because it did not appear to negatively affect
the outcome of subsequent bypass procedures.
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Objectives: Improvised explosive devices (IEDs) and
rocket propelled grenades (RPGs) encountered in combat
situations cause a unique pattern of injuries unlike that seen
in civilian trauma. The purpose of this study was to charac-
terize the presentation, diagnosis and management of vas-
cular injuries caused by these multiple high velocity frag-
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